Sara Grootwassink Lewis
CIK 1165970 · E.V.P. & CFO · last filed 2026-06-02
Sara Grootwassink Lewis is an E.V.P. & CFO who has filed 90 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for FCX, was dated Jun 2, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.07M
8
90
-$1.52M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FCX | Director | 34,000 | $72.47 | $2.46M | $226.0K | 8 | 2026-06-02 |
| WY | Director | 26,023 | $23.38 | $608.4K | $297.2K | 15 | 2026-05-19 |
| HEALTHPEAK PROPERTIES, INC. (PEAK) Delisted | Director | 65,488 | $17.10 | $1.12M | $588.8K | 12 | 2026-05-07 |
| PS BUSINESS PARKS, INC./MD (PSB) Delisted | Director | 8,868 | $187.44 | $1.66M | -$2.26M | 15 | 2018-06-18 |
| PCL | Director | 0 | $47.37 | $0 | $0 | 14 | 2016-02-19 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Director | — | $8.22 | — | $0 | 1 | 2015-05-18 |
| CAPITALSOURCE INC (CSE) Delisted | Director | 15,050 | — | — | $66.4K | 21 | 2013-04-29 |
| Elme Communities (WRE) Delisted | E.V.P. & CFO | 46,127 | $17.57 | $810.5K | -$436.4K | 4 | 2008-12-17 |
Recent Filings
90 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | FCX | Grant (A) | +2,800 | $0 | EDGAR |
| 2026-05-19 | WY | Grant (A) | — | $0 | EDGAR |
| 2026-05-07 | HEALTHPEAK PROPERTIES, INC. (PEAK) Delisted | Grant (A) | +9,744 | $0 | EDGAR |
| 2025-12-18 | WY | Buy (P) | +4,500 | $106.2K | EDGAR |
| 2025-08-13 | WY | Buy (P) | +4,000 | $101.1K | EDGAR |
| 2025-06-03 | FCX | Grant (A) | +4,900 | $0 | EDGAR |
| 2025-05-13 | WY | Grant (A) | — | $0 | EDGAR |
| 2025-04-29 | HEALTHPEAK PROPERTIES, INC. (PEAK) Delisted | Grant (A) | +10,657 | $0 | EDGAR |
| 2025-04-28 | HEALTHPEAK PROPERTIES, INC. (PEAK) Delisted | Buy (P) | +6,000 | $105.9K | EDGAR |
| 2024-06-04 | FCX | Grant (A) | +3,500 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.